ABCL logo

AbCellera Biologics Inc. (ABCL) Current assets

annual current assets:

$751.37M-$120.61M(-13.83%)
December 31, 2024

Summary

  • As of today (July 26, 2025), ABCL annual total current assets is $751.37 million, with the most recent change of -$120.61 million (-13.83%) on December 31, 2024.
  • During the last 3 years, ABCL annual current assets has fallen by -$178.43 million (-19.19%).
  • ABCL annual current assets is now -26.73% below its all-time high of $1.03 billion, reached on December 31, 2022.

Performance

ABCL Current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLbalance sheet metrics

quarterly current assets:

$764.98M+$13.61M(+1.81%)
March 31, 2025

Summary

  • As of today (July 26, 2025), ABCL quarterly total current assets is $764.98 million, with the most recent change of +$13.61 million (+1.81%) on March 31, 2025.
  • Over the past year, ABCL quarterly current assets has dropped by -$48.97 million (-6.02%).
  • ABCL quarterly current assets is now -34.86% below its all-time high of $1.17 billion, reached on March 31, 2022.

Performance

ABCL quarterly current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLbalance sheet metrics

Current assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

ABCL Current assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-13.8%-6.0%
3 y3 years-19.2%-34.9%
5 y5 years+5844.4%-

ABCL Current assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-26.7%at low-33.1%+3.0%
5 y5-year-26.7%+5844.4%-34.9%+571.0%
alltimeall time-26.7%+5844.4%-34.9%+5952.0%

ABCL Current assets History

DateAnnualQuarterly
Mar 2025
-
$764.98M(+1.8%)
Dec 2024
$609.18M(-1.1%)
$751.37M(+1.1%)
Sep 2024
-
$742.88M(-3.7%)
Jun 2024
-
$771.55M(-5.2%)
Mar 2024
-
$813.95M(-6.7%)
Dec 2023
$616.11M(+19.5%)
$871.99M(-5.2%)
Sep 2023
-
$919.52M(-1.2%)
Jun 2023
-
$930.74M(-1.1%)
Mar 2023
-
$940.65M(-8.3%)
Dec 2022
$515.42M
$1.03B(-1.9%)
DateAnnualQuarterly
Sep 2022
-
$1.05B(-8.6%)
Jun 2022
-
$1.14B(-2.6%)
Mar 2022
-
$1.17B(+26.3%)
Dec 2021
$388.77M(+102.3%)
$929.80M(+15.7%)
Sep 2021
-
$803.75M(-7.0%)
Jun 2021
-
$864.00M(-4.8%)
Mar 2021
-
$907.98M(+11.6%)
Dec 2020
$192.21M(+1671.9%)
$813.33M(+613.4%)
Sep 2020
-
$114.00M(+801.9%)
Dec 2019
$10.85M(+71.4%)
$12.64M
Dec 2018
$6.33M
-

FAQ

  • What is AbCellera Biologics Inc. annual total current assets?
  • What is the all time high annual current assets for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. annual current assets year-on-year change?
  • What is AbCellera Biologics Inc. quarterly total current assets?
  • What is the all time high quarterly current assets for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. quarterly current assets year-on-year change?

What is AbCellera Biologics Inc. annual total current assets?

The current annual current assets of ABCL is $751.37M

What is the all time high annual current assets for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high annual total current assets is $1.03B

What is AbCellera Biologics Inc. annual current assets year-on-year change?

Over the past year, ABCL annual total current assets has changed by -$120.61M (-13.83%)

What is AbCellera Biologics Inc. quarterly total current assets?

The current quarterly current assets of ABCL is $764.98M

What is the all time high quarterly current assets for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high quarterly total current assets is $1.17B

What is AbCellera Biologics Inc. quarterly current assets year-on-year change?

Over the past year, ABCL quarterly total current assets has changed by -$48.97M (-6.02%)
On this page